Davidson Ashley G, Bell Rebecca J, Lees George E, Kashtan Clifford E, Davidson George S, Murphy Keith E
Department of Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843-4467, USA.
J Vet Intern Med. 2007 May-Jun;21(3):394-401. doi: 10.1892/0891-6640(2007)21[394:gcoarh]2.0.co;2.
Autosomal recessive hereditary nephropathy (ARHN) in the English Cocker Spaniel is caused by a type IV collagen defect, but the underlying mutation is unknown.
One hundred thirty-four English Cocker Spaniels (12 with ARHN, 8 obligate carriers, and 114 others), 3 mixed breed dogs with X-linked hereditary nephropathy (XLHN), and 7 other dogs without hereditary nephropathy were included.
Diagnosis of ARHN was based on transmission electron microscopy and immunostaining of kidney. Quantitative real time reverse transcriptase polymerase chain reaction (qRT-PCR) was used to compare COL4A3, COL4A4, and COL4A5 mRNA concentrations in the renal cortex from ARHN-affected English Cocker Spaniels, XLHN-affected dogs, and dogs without hereditary nephropathy. The entire coding region of COL4A4 was sequenced in 2 ARHN-affected dogs, 2 obligate carriers, 2 English Cocker Spaniels of unknown status, and 2 healthy mixed breed dogs. The exon containing the mutation was sequenced for all 134 English Cocker Spaniels.
Quantitative real time RT-PCR implicated COL4A4 as the gene harboring the mutation, and sequencing identified a single nucleotide substitution at base 115 as the cause of ARHN in English Cocker Spaniels. This mutation, which causes a premature stop codon in exon 3 of COL4A4, was segregated with clinical status in all affected dogs and obligate carriers. The mutation also was identified in 39 of 114 other English Cocker Spaniels with previously unknown status.
The cause of this disease has been identified, and use of a test for the mutation will permit eradication of ARHN in the English Cocker Spaniel.
英国可卡犬的常染色体隐性遗传性肾病(ARHN)由IV型胶原蛋白缺陷引起,但潜在突变未知。
纳入了134只英国可卡犬(12只患有ARHN,8只必然携带者,以及114只其他犬)、3只患有X连锁遗传性肾病(XLHN)的混血犬和7只无遗传性肾病的其他犬。
ARHN的诊断基于肾脏的透射电子显微镜检查和免疫染色。采用定量实时逆转录聚合酶链反应(qRT-PCR)比较受ARHN影响的英国可卡犬、受XLHN影响的犬以及无遗传性肾病的犬肾皮质中COL4A3、COL4A4和COL4A5 mRNA的浓度。对2只受ARHN影响的犬、2只必然携带者、2只状态未知的英国可卡犬和2只健康混血犬的COL4A4整个编码区进行测序。对所有134只英国可卡犬包含该突变的外显子进行测序。
定量实时RT-PCR表明COL4A4是携带突变的基因,测序确定第115位碱基处的单核苷酸替换是英国可卡犬ARHN的病因。该突变导致COL4A4外显子3出现提前终止密码子,在所有患病犬和必然携带者中与临床状态相关。在114只其他状态未知的英国可卡犬中也有39只检测到该突变。
已确定该疾病的病因,通过检测该突变可根除英国可卡犬中的ARHN。